Medicare Enrolled

Dr. Jivesh Sharma, MD

Hematology & Oncology · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7777 FOREST LN STE B242, Dallas, TX 75230
2147391706
In practice since 2005 (20 years)
NPI: 1588653406 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sharma

Dr. Jivesh Sharma is a hematology & oncology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sharma performed 1,063 Medicare services across 397 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sharma received a total of $12,682 from 97 pharmaceutical and/or device companies across 628 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 49% volume in TX $12,682 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,063
Medicare services
Top 49% in TX for hematology & oncology
397
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~53 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Complete blood count (CBC) with differential 181 $8 $32
Comprehensive metabolic blood panel 156 $10 $50
Office visit, established patient (30-39 min) 156 $102 $275
Blood draw (venipuncture) 116 $8 $10
Injection of additional new drug or substance into vein 107 $12 $70
Administration of chemotherapy into vein, 1 hour or less 77 $104 $412
Office visit, established patient, complex (40-54 min) 68 $140 $350
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 63 $23 $100
Drug injection, under skin or into muscle 42 $11 $60
Hospital follow-up visit, high complexity 34 $93 $250
Office visit, established patient (20-29 min) 25 $71 $175
New patient office visit (45-59 min) 13 $130 $400
Initial hospital admission, high complexity 13 $136 $500
New patient office visit (30-44 min) 12 $88 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.9% high complexity
21.3% medium
72.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,682
Total received (2018-2024)
Avg $1,812/year across 7 years
Top 27% in TX for hematology & oncology
97
Companies
628
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,409 (90.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,273 (10.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,584
2023
$897
2022
$2,338
2021
$2,767
2020
$1,182
2019
$2,010
2018
$904

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$973
Novartis Pharmaceuticals Corporation
$890
Astellas Pharma US Inc
$733
AstraZeneca Pharmaceuticals LP
$730
Janssen Biotech, Inc.
$638
Incyte Corporation
$500
E.R. Squibb & Sons, L.L.C.
$473
Merck Sharp & Dohme LLC
$350
Gilead Sciences, Inc.
$319
Merck Sharp & Dohme Corporation
$305
Daiichi Sankyo Inc.
$253
Bayer HealthCare Pharmaceuticals Inc.
$243
Eisai Inc.
$220
GENZYME CORPORATION
$210
Takeda Pharmaceuticals U.S.A., Inc.
$209
Genentech USA, Inc.
$207
Lilly USA, LLC
$204
Puma Biotechnology, Inc.
$199
Dendreon Pharmaceuticals LLC
$198
Amgen Inc.
$196
Celgene Corporation
$180
Seagen Inc.
$151
Kite Pharma, Inc.
$149
EISAI INC.
$147
BeiGene USA, Inc.
$140
ABBVIE INC.
$140
ARRAY BIOPHARMA INC
$138
Coherus Biosciences Inc.
$132
Epizyme, Inc.,
$128
Rigel Pharmaceuticals, Inc.
$127
EMD Serono, Inc.
$124
Karyopharm Therapeutics Inc.
$122
Ethicon US, LLC
$122
GlaxoSmithKline, LLC.
$115
Blueprint Medicines Corporation
$114
Regeneron Healthcare Solutions, Inc.
$107
Taiho Oncology, Inc.
$102
AbbVie Inc.
$99
Ipsen Biopharmaceuticals, Inc
$95
Sirtex Medical Inc
$86
SOBI, INC
$82
Kyowa Kirin, Inc.
$81
TESARO, Inc.
$80
Octapharma USA, Inc.
$80
Stemline Therapeutics Inc.
$77
Deciphera Pharmaceuticals Inc.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
Exelixis Inc.
$75
Lexicon Pharmaceuticals, Inc.
$67
Pharmacyclics LLC, An AbbVie Company
$64
Adaptive Biotechnologies Corporation
$59
Alexion Pharmaceuticals, Inc.
$53
Seattle Genetics, Inc.
$52
CTI BioPharma Corp.
$49
AMAG Pharmaceuticals, Inc.
$48
Myovant Sciences Inc.
$48
Bayer Healthcare Pharmaceuticals Inc.
$47
MEDIVATION FIELD SOLUTIONS LLC
$46
Pharmacyclics LLC, an AbbVie Company
$44
Verastem, Inc.
$43
G1 Therapeutics, Inc.
$40
JAZZ PHARMACEUTICALS INC.
$39
Janssen Pharmaceuticals, Inc
$38
Organon LLC
$36
Alnylam Pharmaceuticals Inc.
$36
ADC Therapeutics America, Inc.
$35
PUMA BIOTECHNOLOGY, INC.
$35
Sun Pharmaceutical Industries Inc.
$35
PharmaEssentia USA Corporation
$35
Clovis Oncology, Inc.
$29
Janssen Scientific Affairs, LLC
$27
Tempus AI, Inc
$27
EUSA Pharma (US) LLC
$26
Helsinn Therapeutics (U.S.), Inc.
$25
Novo Nordisk Inc
$24
SpringWorks Therapeutics, Inc.
$23
Genmab U.S., Inc.
$22
Agios Pharmaceuticals, Inc.
$21
Acceleron Pharma, Inc.
$21
Aveo Pharmaceuticals, Inc.
$20
ADMA BioManufacturing LLC
$20
Aurobindo Pharma USA, Inc.
$19
Verity Pharmaceuticals Inc.
$19
Teva Pharmaceuticals USA, Inc.
$19
TAIHO ONCOLOGY, INC.
$19
Acrotech Biopharma LLC
$18
Acrotech Biopharma Inc.
$18
Array BioPharma Inc.
$17
Inari Medical, Inc.
$17
Blue Earth Diagnostics Limited
$17
GE HEALTHCARE
$15
Mylan Institutional Inc.
$15
Fortovia Therapeutics, Inc.
$14
GE HealthCare
$13
Global Blood Therapeutics, Inc.
$12
Secura Bio, Inc.
$12
INSYS Therapeutics Inc
$11
Top 3 companies account for 20.5% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Alecensa · BELEODAQ · BESPONSA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · Esperoct · FARESTON · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · Fabhalta · Farydak · Fulphila · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARQIBO · MEKINIST · MONJUVI · NERLYNX · NEUWAVE Flex Microwave Ablation System · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rubraca · S · SANCUSO · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Trelstar · Trodelvy · Truxima · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vanflyta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,193 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Dallas?
Compare hematology & oncology specialists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
134
Per 100K population
5.1
County median income
$74,149
Nearest hospital
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sharma is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sharma experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Sharma performed 181 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $12,682 from 97 companies across 628 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other hematology & oncology specialists in Dallas?
Dr. Sharma's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →